Description

7-(4-Methoxybutoxy)-3,4-Dihydroquinolin-2(1H)-One is a high-purity organic compound serving as a critical advanced intermediate in modern pharmaceutical synthesis. Its molecular structure makes it a valuable building block for developing novel active pharmaceutical ingredients (APIs) with targeted therapeutic effects. This compound is primarily required by research institutions and pharmaceutical manufacturers engaged in the development of new chemical entities and complex organic molecules.

Application

• Pharmaceutical Intermediate: A key synthetic precursor in the research and development of new drug candidates, particularly in central nervous system (CNS) and metabolic disorder therapeutic areas.
• Organic Synthesis Building Block: Used in multi-step synthesis for constructing complex heterocyclic frameworks common in modern medicinal chemistry.
• Chemical Research & Development: Employed in academic and industrial R&D labs for method development, structure-activity relationship (SAR) studies, and novel reaction pathway exploration.
• Active Pharmaceutical Ingredient (API) Synthesis: Integral in the scalable production process of specific APIs, requiring high-purity intermediates to ensure final product quality and regulatory compliance.
• Process Chemistry: Used for optimizing synthetic routes, improving yield, and developing cost-effective manufacturing processes for target molecules.

Basic Information

Item	Details
Product Name	7-(4-Methoxybutoxy)-3,4-Dihydroquinolin-2(1H)-One
CAS No.	1770391-64-4
Molecular Formula	C14H19NO3
Molecular Weight	249.31 g/mol
Synonyms	7-(4-Methoxybutoxy)-1,2,3,4-tetrahydroquinolin-2-one; 2(1H)-Quinolinone, 7-(4-methoxybutoxy)-3,4-dihydro-; 7-(4-Methoxybutoxy)-3,4-dihydro-2(1H)-quinolinone; 7-(4-Methoxybutoxy)-1,2,3,4-tetrahydro-2-quinolone; 1770391-64-4; UNII-9J6I6W05UB; 9J6I6W05UB
EINECS	Contact for details

Quality Control

Our 7-(4-Methoxybutoxy)-3,4-Dihydroquinolin-2(1H)-One is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We adhere to cGMP (current Good Manufacturing Practice) standards where applicable, and our quality protocols are designed to meet the stringent requirements of pharmaceutical and advanced chemical synthesis applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (typically 15-25°C). Keep away from incompatible materials such as strong oxidizing agents. For long-term storage, consider storing under an inert atmosphere to maintain product stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Any single impurity	≤ 0.5%
Residual Solvents (GC)	Meets ICH Q3C guidelines
Loss on Drying	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.